Spinal anaesthesia comparison with hyperbaric drug in ureteroscopic surgeries
- Conditions
- Health Condition 1: N99- Intraoperative and postproceduralcomplications and disorders of genitourinary system, not elsewhere classified
- Registration Number
- CTRI/2023/09/057989
- Lead Sponsor
- Rajarajeswari medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. ASA I and II patients of either sex.
2.Patients aged between 20 to 50 years
3. Patients undergoing elective ureteroscopic surgeries.
1.Patients with known hypersensitivity to local anaesthetic drugs.
2.Pregnant and lactating women.
3.Patients refusal
4.Local site infection and peripheral vascular disease.
5.Diagnosed to have neurological disease.
6.Patients with severe cardiovascular, respiratory, hepatic and renal disease.
7.Patients with coagulation abnormalities.
8.Patients with previous spine surgeries, and spine abnormalities.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the effect of adding 1.6 mg Nalbuphine to 0.5 % Levobupivacaine heavy for ureteroscopic surgeries under spinal anaesthesia for evaluating the duration of analgesia.Timepoint: 0,1,3,5,10 minutes
- Secondary Outcome Measures
Name Time Method Side effects if anyTimepoint: 0,1,3,5,10 minutes
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.